The Blue Mountains Eye Study (BMES) and The Wellcome Trust Case Control Consortium 2 (WTCCC2), Amy Strange, Céline Bellenguez, Xueling Sim, Robert Luben, Pirro G. Hysi, Wishal D. Ramdas, Leonieke M.E. van Koolwijk, Colin Freeman, Matti Pirinen, Zhan Su, Gavin Band, Richard Pearson, Damjan Vukcevic, Cordelia Langford, Panos Deloukas, Sarah Hunt, Emma Gray, Serge Dronov, Simon C. Potter, Avazeh Tashakkori-Ghanbaria, Sarah Edkins, Suzannah J. Bumpstead, Jenefer M. Blackwell, Elvira Bramon, Matthew A. Brown, Juan P. Casas, Aiden Corvin, Audrey Duncanson, Janusz A.Z. Jankowski, Hugh S. Markus, Christopher G. Mathew, Colin N.A. Palmer, Robert Plomin, Anna Rautanen, Stephen J. Sawcer, Richard C. Trembath, Nicholas W. Wood, Ines Barroso, Leena Peltonen, Paul Healey, Peter McGuffin, Fotis Topouzis, Caroline C.W. Klaver, Cornelia M. van Duijn, David A. Mackey, Terri L. Young, Christopher J. Hammond, Kay-Tee Khaw, Nick Wareham, Jie Jin Wang, Tien Y. Wong, Paul J. Foster, Paul Mitchell, Chris C.A. Spencer, Peter Donnelly, Ananth C. Viswanathan
Hum Mol Genet. 2013 Nov 15; 22(22): 4653–4660. Published online 2013 Jul 7. doi: 10.1093/hmg/ddt293